CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0100
+0.0040 (66.67%)
Jul 26, 2024, 4:00 PM EDT - Market closed
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $311.11 thousand as of July 26, 2024. Its market cap has increased by 14.66% in one year.
Market Cap
311.11K
Enterprise Value
1.41M
1-Year Change
14.66%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since July 29, 2019, CNBX Pharmaceuticals's market cap has decreased from $36.05M to $311.11K, a decrease of -99.14%. That is a compound annual growth rate of -61.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 217.47K | -50.58% |
| Dec 29, 2023 | 440.03K | -87.95% |
| Dec 30, 2022 | 3.65M | -72.12% |
| Dec 31, 2021 | 13.10M | -53.50% |
| Dec 31, 2020 | 28.16M | 74.18% |
| Dec 31, 2019 | 16.17M | -55.16% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 817.23B |
| Novo Nordisk | 593.43B |
| UnitedHealth Group | 515.19B |
| Johnson & Johnson | 376.12B |
| Merck & Co. | 318.93B |
| AbbVie | 311.16B |
| AstraZeneca | 247.14B |
| Thermo Fisher | 219.38B |